Life Extension Foundation Supported Trial Finds 7,000 IU Vitamin D Improves Immunological Parameters in HIV-Positive Individuals

Dr. Virginia A. Stallings and colleagues from the Children’s Hospital of Philadelphia published a double-blind, randomized, placebo-controlled trial in which treatment with a 7,000 IU vitamin D3 product benefited HIV-positive children and young adults. The vitamin D supplements used in the trial were provided by the Life Extension Foundation. The publication, titled “High-Dose Vitamin D3 ...